BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11270682)

  • 1. Studies of variability in the PTEN gene among Danish caucasian patients with Type II diabetes mellitus.
    Hansen L; Jensen JN; Ekstrøm CT; Vestergaard H; Hansen T; Pedersen O
    Diabetologia; 2001 Feb; 44(2):237-40. PubMed ID: 11270682
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a common amino acid polymorphism in the p85alpha regulatory subunit of phosphatidylinositol 3-kinase: effects on glucose disappearance constant, glucose effectiveness, and the insulin sensitivity index.
    Hansen T; Andersen CB; Echwald SM; Urhammer SA; Clausen JO; Vestergaard H; Owens D; Hansen L; Pedersen O
    Diabetes; 1997 Mar; 46(3):494-501. PubMed ID: 9032108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin hypersensitivity and resistance to streptozotocin-induced diabetes in mice lacking PTEN in adipose tissue.
    Kurlawalla-Martinez C; Stiles B; Wang Y; Devaskar SU; Kahn BB; Wu H
    Mol Cell Biol; 2005 Mar; 25(6):2498-510. PubMed ID: 15743841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic variability of the SUR1 promoter in relation to beta-cell function and Type II diabetes mellitus.
    Hansen T; Ambye L; Grarup N; Hansen L; Echwald SM; Ferrer J; Pedersen O
    Diabetologia; 2001 Oct; 44(10):1330-4. PubMed ID: 11692183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the polymorphisms in the 5'-untranslated region of PTEN gene with type 2 diabetes in a Japanese population.
    Ishihara H; Sasaoka T; Kagawa S; Murakami S; Fukui K; Kawagishi Y; Yamazaki K; Sato A; Iwata M; Urakaze M; Ishiki M; Wada T; Yaguchi S; Tsuneki H; Kimura I; Kobayashi M
    FEBS Lett; 2003 Nov; 554(3):450-4. PubMed ID: 14623110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes.
    Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T
    Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies of the variability of the hepatocyte nuclear factor-1beta (HNF-1beta / TCF2) and the dimerization cofactor of HNF-1 (DcoH / PCBD) genes in relation to type 2 diabetes mellitus and beta-cell function.
    Ek J; Grarup N; Urhammer SA; Gaede PH; Drivsholm T; Borch-Johnsen K; Hansen T; Pedersen O
    Hum Mutat; 2001 Oct; 18(4):356-7. PubMed ID: 11668623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of the PTEN -9C>G polymorphism with insulin sensitivity and central obesity in Chinese.
    Yang Q; Cao H; Xie S; Tong Y; Zhu Q; Zhang F; Lü Q; Yang Y; Li D; Chen M; Yu C; Jin W; Yuan Y; Tong N
    Gene; 2013 Sep; 527(2):545-52. PubMed ID: 23796801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pten (phosphatase and tensin homologue gene) haploinsufficiency promotes insulin hypersensitivity.
    Wong JT; Kim PT; Peacock JW; Yau TY; Mui AL; Chung SW; Sossi V; Doudet D; Green D; Ruth TJ; Parsons R; Verchere CB; Ong CJ
    Diabetologia; 2007 Feb; 50(2):395-403. PubMed ID: 17195063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in the neurogenin 3 gene (NEUROG) and their relation to altered insulin secretion and diabetes in the Danish Caucasian population.
    Jensen JN; Hansen L; Ekstrøm CT; Pociot F; Nerup J; Hansen T; Pedersen O
    Diabetologia; 2001 Jan; 44(1):123-6. PubMed ID: 11206403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The K121Q variant of the human PC-1 gene is not associated with insulin resistance or type 2 diabetes among Danish Caucasians.
    Rasmussen SK; Urhammer SA; Pizzuti A; Echwald SM; Ekstrøm CT; Hansen L; Hansen T; Borch-Johnsen K; Frittitta L; Trischitta V; Pedersen O
    Diabetes; 2000 Sep; 49(9):1608-11. PubMed ID: 10969849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Restraining PI3K: mTOR signalling goes back to the membrane.
    Harrington LS; Findlay GM; Lamb RF
    Trends Biochem Sci; 2005 Jan; 30(1):35-42. PubMed ID: 15653324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity.
    Sasaoka T; Wada T; Tsuneki H
    Pharmacol Ther; 2006 Dec; 112(3):799-809. PubMed ID: 16842857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Muscle-specific Pten deletion protects against insulin resistance and diabetes.
    Wijesekara N; Konrad D; Eweida M; Jefferies C; Liadis N; Giacca A; Crackower M; Suzuki A; Mak TW; Kahn CR; Klip A; Woo M
    Mol Cell Biol; 2005 Feb; 25(3):1135-45. PubMed ID: 15657439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the coding region of the uncoupling protein 2 gene in obese NIDDM patients: impact of a common amino acid polymorphism on juvenile and maturity onset forms of obesity and insulin resistance.
    Urhammer SA; Dalgaard LT; Sørensen TI; Møller AM; Andersen T; Tybjaerg-Hansen A; Hansen T; Clausen JO; Vestergaard H; Pedersen O
    Diabetologia; 1997 Oct; 40(10):1227-30. PubMed ID: 9349606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes.
    Tang X; Powelka AM; Soriano NA; Czech MP; Guilherme A
    J Biol Chem; 2005 Jun; 280(23):22523-9. PubMed ID: 15824124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocyte nuclear factor-6: associations between genetic variability and type II diabetes and between genetic variability and estimates of insulin secretion.
    Møller AM; Ek J; Durviaux SM; Urhammer SA; Clausen JO; Eiberg H; Hansen T; Rousseau GG; Lemaigre FP; Pedersen O
    Diabetologia; 1999 Aug; 42(8):1011-6. PubMed ID: 10491763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence that SHIP-1 contributes to phosphatidylinositol 3,4,5-trisphosphate metabolism in T lymphocytes and can regulate novel phosphoinositide 3-kinase effectors.
    Freeburn RW; Wright KL; Burgess SJ; Astoul E; Cantrell DA; Ward SG
    J Immunol; 2002 Nov; 169(10):5441-50. PubMed ID: 12421919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A common variation of the PTEN gene is associated with peripheral insulin resistance.
    Grinder-Hansen L; Ribel-Madsen R; Wojtaszewski JF; Poulsen P; Grunnet LG; Vaag A
    Diabetes Metab; 2016 Sep; 42(4):280-4. PubMed ID: 27068875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTEN, a widely known negative regulator of insulin/PI3K signaling, positively regulates neuronal insulin resistance.
    Gupta A; Dey CS
    Mol Biol Cell; 2012 Oct; 23(19):3882-98. PubMed ID: 22875989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.